Important Short Interest Filing: Rockwell Medical Incorporated (NASDAQ:RMTI) Short Interest Increased By 4.69%

November 30, 2016 - By Clifton Ray   ·   0 Comments

Important Short Interest Filing: Rockwell Medical Incorporated (NASDAQ:RMTI) Short Interest Increased By 4.69%

The stock of Rockwell Medical Incorporated (NASDAQ:RMTI) registered an increase of 4.69% in short interest. RMTI’s total short interest was 10.22 million shares in November as published by FINRA. Its up 4.69% from 9.77M shares, reported previously. With 313,300 shares average volume, it will take short sellers 33 days to cover their RMTI’s short positions. The short interest to Rockwell Medical Incorporated’s float is 21.6%. The stock increased 3.34% or $0.21 on November 29, hitting $6.5. Rockwell Medical Inc (NASDAQ:RMTI) has declined 32.92% since April 27, 2016 and is downtrending. It has underperformed by 38.15% the S&P500.

Rockwell Medical, Inc. is a biopharmaceutical firm targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with services and products for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The company has a market cap of $326.12 million. The Firm operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. It currently has negative earnings. The Company’s lead branded drug, Triferic is indicated for iron maintenance.

Insitutional Activity: The institutional sentiment decreased to 0.66 in Q2 2016. Its down 0.24, from 0.9 in 2016Q1. The ratio worsened, as 11 funds sold all Rockwell Medical Inc shares owned while 28 reduced positions. 9 funds bought stakes while 26 increased positions. They now own 10.76 million shares or 10.05% less from 11.96 million shares in 2016Q1.
Palo Capital has 0.13% invested in the company for 49,166 shares. Moreover, Perkins has 4.15% invested in Rockwell Medical Inc (NASDAQ:RMTI) for 478,650 shares. Amer Intll Grp, a New York-based fund reported 27,584 shares. Ny State Common Retirement Fund has invested 0% of its portfolio in Rockwell Medical Inc (NASDAQ:RMTI). Ladenburg Thalmann Fincl Svcs has invested 0% of its portfolio in Rockwell Medical Inc (NASDAQ:RMTI). Moreover, Interocean Cap has 0.04% invested in Rockwell Medical Inc (NASDAQ:RMTI) for 19,165 shares. The New York-based Teachers Advsrs has invested 0% in Rockwell Medical Inc (NASDAQ:RMTI). California Public Employees Retirement last reported 0% of its portfolio in the stock. Susquehanna Gp Ltd Liability Partnership holds 0% or 379,136 shares in its portfolio. Bnp Paribas Arbitrage Sa has 1,862 shares for 0% of their US portfolio. Great West Life Assurance Can holds 0% of its portfolio in Rockwell Medical Inc (NASDAQ:RMTI) for 4,883 shares. Raymond James & Assoc owns 74,250 shares or 0% of their US portfolio. Aqr Cap Mngmt Ltd has 0% invested in the company for 15,956 shares. The Switzerland-based Credit Suisse Ag has invested 0% in Rockwell Medical Inc (NASDAQ:RMTI). The Texas-based Utd Svcs Automobile Association has invested 0% in Rockwell Medical Inc (NASDAQ:RMTI).

Insider Transactions: Since August 12, 2016, the stock had 0 insider buys, and 5 sales for $207,242 net activity. 3,692 shares with value of $26,991 were sold by HOLT KENNETH L on Friday, August 12.

Rockwell Medical Inc (NASDAQ:RMTI) Ratings Coverage

Out of 2 analysts covering Rockwell Medical (NASDAQ:RMTI), 0 rate it a “Buy”, 2 “Sell”, while 0 “Hold”. This means 0 are positive. Rockwell Medical has been the topic of 5 analyst reports since August 6, 2015 according to StockzIntelligence Inc. On Thursday, August 13 the stock rating was upgraded by TheStreet to “Sell”. The firm has “Outperform” rating given on Saturday, August 22 by Oppenheimer. The rating was maintained by Oppenheimer on Thursday, August 6 with “Outperform”. The stock has “Underperform” rating given by Bank of America on Tuesday, November 8. Morgan Stanley initiated Rockwell Medical Inc (NASDAQ:RMTI) on Thursday, August 13 with “Underweight” rating.

RMTI Company Profile

Rockwell Medical, Inc. (Rockwell), incorporated on October 25, 1996, is a biopharmaceutical firm targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with services and products for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Firm operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. The Company’s lead branded drug, Triferic is indicated for iron maintenance.

More notable recent Rockwell Medical Inc (NASDAQ:RMTI) news were published by: Fool.com which released: “3 Ways Rockwell Medical Inc. Could Turn Things Around” on October 07, 2016, also Fool.com with their article: “3 Predictions for Rockwell Medical Inc. in 2016” published on December 10, 2015, Fool.com published: “Will Rockwell Medical Inc. Sink or Swim?” on April 06, 2016. More interesting news about Rockwell Medical Inc (NASDAQ:RMTI) were released by: Fool.com and their article: “Why Rockwell Medical, Inc. Shares Are Crashing Today” published on March 01, 2016 as well as Fool.com‘s news article titled: “Rockwell Medical Stock Upgraded: What You Need to Know” with publication date: August 19, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Clifton Ray


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>